How to Help Your Patients Find Ryaltris in Stock: A Provider's Guide

How to Help Your Patients Find Ryaltris in Stock: A Provider's Guide

You've made the clinical decision to prescribe Ryaltris for your patient's seasonal allergic rhinitis. The combination of Olopatadine and Mometasone in a single nasal spray offers clear advantages — fast-acting antihistamine relief plus sustained anti-inflammatory action, better taste tolerability than Azelastine-based alternatives, and improved adherence through single-device convenience.

But if the patient can't find it at their pharmacy, none of that matters.

This guide provides actionable steps you can take — at the point of prescribing and within your practice workflow — to maximize the chance that your patients successfully fill their Ryaltris prescriptions.

Current Availability Landscape

Ryaltris (Olopatadine Hydrochloride 665 mcg / Mometasone Furoate 25 mcg per spray) has been commercially available in the U.S. since August 2022. As of 2026:

• No formal shortage exists. Ryaltris is not listed on the FDA or ASHP drug shortage databases.
• No generic is available. Hikma Specialty USA is the sole U.S. manufacturer.
• Pharmacy-level stock-outs are common — especially during peak allergy seasons and at chain pharmacies with automated, volume-based inventory systems.
• Cash price remains high: $235–$333 per bottle without insurance or savings programs.

The challenge isn't that Ryaltris doesn't exist on pharmacy shelves — it's that it doesn't exist on enough pharmacy shelves at the times patients need it most.

Why Patients Can't Find Ryaltris

Understanding the root causes helps you address them proactively:

Single-Source Supply

With no generic manufacturers, Ryaltris inventory is entirely dependent on Hikma's production and distribution. Any lag in the supply chain — even minor ones — can cause localized stock-outs with no alternative source to fill the gap.

Chain Pharmacy Inventory Bias

Large pharmacy chains (CVS, Walgreens, Rite Aid) use automated par-level systems that adjust inventory based on dispensing volume. For a brand-name product with relatively lower volume compared to generics, this means many locations don't maintain consistent stock. A pharmacy that fills two Ryaltris prescriptions per month may not keep any bottles on the shelf between fills.

Insurance-Driven Barriers

Prior authorization requirements and step therapy protocols reduce the number of Ryaltris prescriptions that pharmacies fill, which in turn reduces the incentive for pharmacies to stock it. This creates a circular problem: low stock leads to unfilled prescriptions, which leads to lower dispensing volume, which leads to even lower stock levels.

Seasonal Demand Patterns

Ryaltris is indicated for seasonal allergic rhinitis. Prescribing volume concentrates heavily in March–May and September–November. Pharmacies that carry zero or one bottle during off-season months face sudden spikes they can't easily accommodate.

What Providers Can Do: 5 Practical Steps

Step 1: Check Availability Before the Patient Leaves

The single most impactful thing you can do is verify that Ryaltris is available at the patient's preferred pharmacy before they leave your office. Use Medfinder for Providers to check real-time stock at pharmacies near the patient's home or work.

If the preferred pharmacy doesn't have it, you can:

• Send the prescription to a pharmacy that does have stock
• Recommend the patient call ahead to confirm before making the trip
• Suggest an independent pharmacy as an alternative

This single step can prevent the majority of "I couldn't find it" callbacks.

Step 2: E-Prescribe Strategically

Where you send the prescription matters. Consider these strategies:

• Independent pharmacies tend to be more responsive to special orders and may proactively stock Ryaltris for returning patients.
• Mail-order pharmacies typically maintain broader brand-name inventory and can ship directly to the patient's home.
• Specialty or allergy-focused pharmacies may stock Ryaltris as part of their core inventory.
• Avoid sending Ryaltris prescriptions to pharmacies where you know stock is unreliable, if alternatives exist nearby.

Step 3: Provide Savings Information at the Point of Prescribing

Cost-related fill failures are common with brand-name medications. Address this proactively:

• Ryaltris Savings Card: Commercially insured patients can pay as little as $39/bottle. Cash-paying patients can pay as low as $45.52/bottle. Maximum benefit of $200/bottle. Direct patients to us.ryaltris.com/savings-and-support or provide the phone number: 1-800-631-2174.
• Patient assistance programs: For uninsured or underinsured patients, Hikma offers additional support. Resources also available through NeedyMeds and RxAssist.
• Coupon cards: GoodRx and SingleCare offer Ryaltris coupons in the $245–$280 range — still expensive, but lower than the $333 average cash price.

Handing patients a printed savings card or texting them the link before they leave your office significantly increases fill rates.

Step 4: Prepare Prior Authorization Documentation

Many insurance plans require prior authorization for Ryaltris. Streamline the process by:

• Documenting prior trials of OTC corticosteroids (Fluticasone, Mometasone) and their inadequate response
• Noting prior trials of OTC antihistamines (oral or nasal) if applicable
• Including symptom severity scores and functional impact (sleep disruption, work/school impairment)
• Citing the clinical rationale for combination therapy over separate agents — particularly adherence benefits and the clinical advantage of concurrent antihistamine + corticosteroid delivery

Pre-populating your PA templates with this language can reduce turnaround time and approval denials.

Step 5: Have a Documented Backup Plan

For every Ryaltris prescription, consider having a pre-determined alternative on file. This way, if the pharmacy can't fill Ryaltris and the patient calls back, your staff can quickly pivot:

• First alternative: Generic Azelastine/Fluticasone (Dymista generic) — similar dual-action, widely available, $30–$80 with coupons
• Second alternative: Separate prescriptions for generic Mometasone + OTC Azelastine (Astepro) — two sprays, but very affordable ($20–$40 total)
• OTC-only option: Flonase (Fluticasone) + oral antihistamine (Cetirizine, Loratadine) — for patients who want the simplest, cheapest approach

Alternative Prescribing Considerations

When Ryaltris is unavailable or cost-prohibitive, these alternatives provide comparable clinical benefit:

• Dymista / generic Azelastine/Fluticasone: Most similar mechanism. Note that Azelastine may cause more taste disturbance and drowsiness than Olopatadine.
• Mometasone Furoate (generic Nasonex): Same corticosteroid as Ryaltris. Add OTC Astepro for antihistamine component. Cost-effective but requires two devices.
• Fluticasone Propionate (Flonase, OTC): Widely available. Combine with Astepro or oral antihistamine for dual-action coverage.

For a patient-facing comparison of alternatives, share our guide: alternatives to Ryaltris.

Workflow Tips for Your Practice

Integrate these practices into your allergy season workflow:

• Add Medfinder to your workflow. Bookmark medfinder.com/providers on clinic computers for quick availability checks.
• Stock savings cards. Keep printed Ryaltris Savings Cards in your sample closet or at the checkout desk.
• Pre-authorize during scheduling. If a patient is coming in for an allergy visit and you anticipate prescribing Ryaltris, start the PA process before the appointment.
• Use samples for bridging. Request Ryaltris samples from Hikma to bridge patients while they wait for pharmacy stock or insurance approval.
• Educate patients proactively. Share resources like how to find Ryaltris in stock and how to save money on Ryaltris so patients can advocate for themselves.

Final Thoughts

Prescribing Ryaltris is the easy part. Getting it into your patients' hands requires navigating a landscape of inventory gaps, insurance hurdles, and cost barriers. By checking availability before prescribing, providing savings resources, preparing for prior authorizations, and having backup alternatives ready, you can dramatically reduce fill failures and improve patient satisfaction.

Tools like Medfinder for Providers make this process faster and more reliable. The goal is straightforward: when you prescribe Ryaltris, your patient should be able to fill it — the same day, at a price they can afford.

For more provider resources, see our Ryaltris shortage briefing for providers and how to help patients save money on Ryaltris.